Jean-François Masson is an associate professor of chemistry at the Université de Montréal. His expertise encompasses biosensing with plasmonic materials, instrument development, surface chemistry to minimize biofouling and detection of proteins and drugs directly in crude biofluids. He received a BSc in chemistry from Université de Sherbrooke in 2001, during which he was exposed to industrial research as an intern in several companies. He completed a PhD in analytical chemistry at Arizona State University in 2005, where he initiated his research on surface plasmon resonance and biosensing. Following a post-doctoral fellowship at Georgia Tech on ATP sensing in clinical studies with rats, he was hired as an assistant professor in 2007 at Université de Montréal.
Masson received several awards during his training and as a professor. He has published more than 40 articles since 2004 in various analytical and physical chemistry journals. His research has led to filing seven patents on diverse instrumental, materials or surface chemistry innovations for biosensing. A series of these patents were licensed to Rose Street Labs in 2005. His recent research on the detection of methotrexate, a common chemotherapy drug, led to the development of an analytical method tested with clinical samples and thus, several collaborations spawned with biochemistry labs of local hospitals.